WO1997035519A1 - Condensate colorimetric nitrogen oxide analyzer - Google Patents

Condensate colorimetric nitrogen oxide analyzer Download PDF

Info

Publication number
WO1997035519A1
WO1997035519A1 PCT/US1997/004848 US9704848W WO9735519A1 WO 1997035519 A1 WO1997035519 A1 WO 1997035519A1 US 9704848 W US9704848 W US 9704848W WO 9735519 A1 WO9735519 A1 WO 9735519A1
Authority
WO
WIPO (PCT)
Prior art keywords
reagent
exhalate
conduit
chamber
condensing
Prior art date
Application number
PCT/US1997/004848
Other languages
French (fr)
Inventor
Benjamin M. Gaston, Iv
John F. Hunt
Original Assignee
Gaston Benjamin M Iv
Hunt John F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gaston Benjamin M Iv, Hunt John F filed Critical Gaston Benjamin M Iv
Priority to CA002248321A priority Critical patent/CA2248321C/en
Priority to JP9534575A priority patent/JP2000507462A/en
Priority to AU23461/97A priority patent/AU724417B2/en
Priority to EP97916226A priority patent/EP0897284A4/en
Publication of WO1997035519A1 publication Critical patent/WO1997035519A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/08Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/083Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption

Definitions

  • the invention provides a device for determination of the content of higher oxides of nitrogen in exhaled breath condensate which comprises a conduit having an exhalate condensing portion with an inlet and an outlet (the inlet canbe configured to fit with a mechanical respirator or, for direct use by the patient, an inlet assembly providing one-way ingress of ambient atmosphere to the device can be associated with the inlet of the conduit exhalate condensing portion); a coolant jacket coaxially surrounding said exhalate condensing portion; a gas release port; and, in enclosed fluid communication with said conduit exhalate condensing portion outlet, a sample assay assembly comprising (i) a translucent analysis chamber attached to the outlet to receive condensate fluid and having a reagent entry port, (ii) a reagent chamber in enclosed fluid communication with the reagent entry port and (iii) a pliable element connecting the outlet and the analysis chamber and forming a portion of the reagent chamber such that flexion of the pliable element closes communication between
  • the device is disposable and inexpensive, and is used to collect human exhalate for colorimetric assay of liquid and gas phase nitrogen oxides to assist in evaluation of airway inflammation.
  • the device further comprises an inlet assembly providing one-way ingress of ambient atmosphere to the exhalate condensing conduit inlet. This is ideal for the patient who is breathing directly into the device, rather than the situation where the device is connected to a mechanical respirator.
  • the device further comprises, between the inlet assembly and the exhalate condensing conduit portion, a filter capable of removing particulate matter from exhaled air which passes therethrough.
  • the device further comprises a coolant material in the coolant jacket.
  • the device further comprises a reagent composition capable of detecting a nitrite or nitrate in an exhalation condensate sample.
  • the device further comprises a reagent- permeable membrane in the reagent entry port.
  • the device further comprises a rupturable membrane in the reagent entry port.
  • the inlet assembly further includes therein a filter capable of removing ambient nitrogen oxides from exhalate passing therethrough.
  • the exhalate condensing conduit portion comprises a single lumen conduit having a lumen diameter sufficient to cause substantially no resistance to the flow of exhalate therethrough.
  • the exhalate condensing conduit portion comprises a plurality of conduit tubules having a collective lumen diameter sufficient to cause substantially no resistance to the flow of exhalate therethrough.
  • the pu ⁇ ose of this invention is to condense exhaled lung gas and vapor for aqueous phase nitrogen oxide analyses. This will assist in the evaluation of the human airways' production of nitrogen oxides in both gas and several liquid phase states, including nitrite and nitrate, with potential for multiple other studies to help delineate the lung's redox environment and the airways' degree of inflammation.
  • the invention is comprised of cold tolerant materials and consists of two tubing units, one inside the other. Surrounding the inner tube or set of tubes, and contained by the outer tube, is a chemical substance which has a high specific heat, and therefore, once frozen, can maintain freezing temperatures for an extended period of time.
  • the disposable unit can be frozen in a standard size home freezer and then connected together with collection and analysis instruments as a compact integral unit.
  • a port through which the subject breathes Attached to the proximal portion of the unit is a port through which the subject breathes.
  • This consists of two one-way valves which direct atmospheric air or selected gases to the patient's lungs during inspiration, and channel exhaled gas down a condensing tube. Gas moves in only one direction through the condensing apparatus.
  • a microporous filter Inserted between the breathing port's mouthpiece and the condensing chamber is a microporous filter which traps all small part icles(such as saliva or sputum), is impermeable to liquids, but allows gas and vaporized fluids of less than 0.3 microns in diameter to pass. This acts as a saliva trap and may also act as a filter for the larger fluid particles which may be aerosolized in the larger airways.
  • the distal end of the condensing chamber tube(s) is attached to a collecting apparatus which utilizes gravity to trap condensed fluid.
  • a collecting apparatus which utilizes gravity to trap condensed fluid.
  • a clear plastic analyzing chamber in which the sample is sequentially warmed, sealed, reacted with colorimetric reagents and analyzed spectrophotometrically by the non-disposable colorimeter.
  • the patient breathes comfortably in and out through the mouthpiece.
  • Lung fluid vapor collects on the inner surface of the inner tube(s) of the condensing apparatus starting immediately.
  • Gravity carries the larger droplets down the tube, these droplets recruiting other small droplets on their trip to the collecting vial distally.
  • the condensed fluid can be expressed down the inner tube with a device similar to a syringe plunger.
  • Aqueous phase nitrite and nitrate can be measured by standard colorimetric assays, and can be reasonably quantified by simple tests performed by patients in their homes.
  • Figure 1 is a side elevation view, partially in section, of the device of the invention.
  • Figure 2A is a side sectional elevation view of a preferred embodiment of the sample assay assembly of the device with the non-disposable analyzer, and includes a top view of the connecting pincer valve.
  • Figure 2B is a top view of the pincer which flexes the pliable element of the sample assay assembly.
  • Figure 3 is a histogram showing the results of the nitrite assay performed as described in Example 2.
  • Figure 4 is a histogram showing the results of the nitrate assay performed as described in Example 2. Detailed Description of the Invention
  • the device of the invention has several advantages, including:
  • the device can be made with easily available materials.
  • the cooling substance in the condensing chamber can be water, or a viscous substance with a high specific heat.
  • the device can also be made, as described above, without refrigerant, utilizing a gas/membrane or gas/aqueous reaction compartment.
  • mouthpiece 1 is formed as an integral element with low resistance one-way valve 2 allowing inspiration of air into the device of the invention resulting from inhalation through it by the user.
  • Low resistance one-way valve 2 optionally contains potassium permanganate and a charcoal filter to remove ambient nitrogen oxides.
  • Mouthpiece 1 and low resistance one-way valve 2 are further integral with low resistance one-way valve 3 to direct all expired gas from the user into the remaining elements of the device.
  • Integral with and downstream of low resistance one-way valve 3 is low resistance filter 4, containing elements which removes all particulates greater than .03 ⁇ M in diameter.
  • condensing chamber 5 Connected downstream to low resistance filter 4 is condensing chamber 5 which consists of either a single, long inert plastic tube of sufficient diameter to be of low resistance to air expired into the device, or a bundle of shorter, parallel, inert plastic tubes of sufficient number to provide minimal resistance to airflow. Condensing chamber 5 is in continuity with, i.e. , receives air arising from filter 4. Coolant chamber or jacket 6 contains an aqueous solution of sufficient osmolality to cause freezing point depression to just above the minimum temperature of the average household freezer, e.g. , in a range of ⁇ 15°F, preferably below 0°F.
  • Condensing chamber 5 is completely sealed from exposure to coolant chamber 6.
  • Essentially coolant chamber 6 coaxially surrounds condensing chamber 5 so as to control the temperature within condensing chamber 6.
  • Condensing chamber 6 is continuous with a conduit that divides to condensate delivery conduit 7 and exhaust port 8.
  • a reagent imprednated mesh, such as filter paper, can optionally be situated in conduit 7 for reagent combination with condensate prior to their arrival in sample analysis assembly 9.
  • Exhaust port 8 comprises a one-way, low-resistance valve through which air, in which the condensate has been analyzed, is expelled from the device of the invention.
  • Sample analysis assembly 9 is connected to the outlet of condensing chamber 5 through condensate delivery conduit 7 and is described in detail with reference to Figure 2A.
  • Analyzer 10 which is not a component of the disposable device of the invention, includes a wavelength-filtered light source and photometer bulb, for measuring the specific absorbance of reacted reagent in sample assay assembly 8, and a computer both for calculating and displaying the corresponding nitrogen oxide content of the sample in assembly 8 and for calibrating the absorbance/concentration relationship based on standard samples is shown as an association of conventional elements in essentially block form.
  • Elements 1 through 9 of the device of the present invention form a disposable unit which is stored under refrigeration, preferably frozen, until used. In contrast, analyzer 10 is not disposable and is maintained at room temperature.
  • the disposable unit comprising elements 1-9 is removed from frozen storage and placed as a unit in connecting housing 11, which is attached to analyzer 10 in such a way that analysis assembly 9 fits snugly into housing 11.
  • "Housing" serves to hold the disposable and non-disposable units together at the appropriate orientation, and to prevent the subject user's hand from becoming affected by the cold of the disposable device while holding the apparatus during gas sampling.
  • Sample analysis assembly 9 is surrounded by a thermostatically controlled heating coil 12 attached to housing 11 and analyzer 10 which brings the sample and test reagents to 25 °C. Heating coil 12 is part of the non-disposable unit.
  • sample assay assembly 9 comprises continuous with a round, hard- plastic analysis chamber 13, reagent chamber 14 and pliable element 15.
  • Conduit 7 and assembly 9 are brought into juxtaposition and are connected by pliable element 15, which is a soft-plastic component that extends beyond the diameter of conduit 7.
  • pliable element 15 is a soft-plastic component that extends beyond the diameter of conduit 7.
  • opening 16 is positioned at the bottom of analysis chamber 13 in which is positioned a fluid-permeable membrane or a thin, plastic rupturable membrane.
  • Reagent(s) for colorimetric nitrogen oxide salt analysis could be a diazo reagent, or such a reagent in conjunction with nitrate reductase and appropriate cofactors to enable both nitrite and nitrate to be measured simultaneously.
  • Other reactions such as reduction of nitrite and nitrate to nitric oxide in vanadium chloride, followed by reaction with oxyhemoglobin to achieve a colorimetric shift in the Soret band, and including heterolytic cleavage of S-NO bonds with mercuric chloride followed by diazo analysis could also be employed.
  • the condensate of exhaled air passed into analysis chamber 13. Thereafter, the user squeezes pliable element 15, using pincer 17 (shown in Figure 2).
  • Asthma is an inflammatory disease which leads to airway obstruction.
  • Current tests of disease severity are based on measures of obstruction, alterations of which are late findings in asthma exacerbations.
  • Recent studies reveal that expression of inducible nitric oxide synthase (iNOS) is increased in the airway epithelial and inflammatory cells of patients with asthma.
  • the activity of iNOS is known to be reflected in high concentrations of nitric oxide (NO • ) gas measured in the expired air of asthmatic subjects.
  • NO • nitric oxide
  • Saliva free, 0.2 micron particle size-filtered expired vapor was obtained from subjects breathing quietly through a condensing apparatus.
  • Nitrite (NO 2 -) was assayed colorimetrically using Griess reagent.
  • Nitrate (NO 3 -) was assayed by chemiluminescence after reduction in vanadium chloride.
  • nitrate concentrations were likewise significantly elevated in asthmatic subjects (9.48 ⁇ M ⁇ 1.25) relative to controls (5.27 ⁇ M ⁇ 0.51) (p ⁇ 0.01).
  • Tests of airway obstruction are currently the primary modality for objectively assessing severity of inflammatory airway disease. These tests have several limitations, including being effort-dependent, and thus are not suitable for many children and neuro-muscularly handicapped individuals. They also poorly reflect the degree of underlying inflammation.
  • Aqueous phase nitrogen oxides measured in condensed exhalate, are significantly elevated in asthmatic patients, and can be used to distinguish between normal and inflamed airways.

Abstract

Disclosed is a device for determination of the content of higher oxides of nitrogen in exhaled breath condensate which comprises a conduit (7) having an exhaling condensing portion with an inlet and an outlet (the inlet can be configured to fit with a mechanical respirator, or for direct use by a patient, an inlet assembly providing one-way ingress (2) of ambient atmosphere so the device can be associated with the inlet of the conduit exhaling condensing portion); a coolant jacket (6) coaxially surrounding said exhaling condensing portion; a gas release port; and, in an enclosed fluid communication with said conduit exhaling condensing portion outlet, a sample assay assembly (9) comprising the following: (a) a translucent analysis chamber attached to the outlet to receive condensate fluid and having a reagent port; (b) a reagent chamber in enclosed fluid communication with the reagent entry port; and (c) a pliable element connecting the oulet and the analysis chamber and forming a portion of the reagent chamber such that flexion of the pliable element closes communication between the oulet and the analysis chamber and contracts the reagent chamber so as to deliver to the analysis chamber controlled amounts of condensate and reagent. The device is disposable and inexpensive, and is used to collect human exhaling for colorimetric assay of liquid and gas phase nitrogen oxides to assist in evaluation of airway inflammation.

Description

CONDENSATE COLORIMETRIC NITROGEN OXIDE ANALYZER
BACKGROUND OF THE INVENTION
Conventional assessment of severity of airway diseases, including asthma, consists of measures of pulmonary mechanics which are effort dependent and thus not suitable for many pediatric patients, mechanically ventilated patients, or patients with neuromuscular disease. See Crapo R. , Pulmonary-function testing. N. Engl. J. Med., 331; 1:25-30; 1994; and American Thoracic Society/European Respiratory Society: Respiratory mechanics in infants - physiologic evaluation in health and disease, Am. Rev. Respir. Dis. , 1993; 747:474-96. Currently the Peak Expiratory flow meter is the only method commonly available for home use by asthmatics to monitor the state of their airway disease. This test suffers from being an insensitive indicator of airway inflammation, and is effort dependent. Other physiologic parameters require expensive machines and experienced operators to obtain reproducible results. Klein R., Fritz G. Yeung A., McQuade E. , Mansell A., Spirometric Patterns in Childhood Asthma: Peak Flow Compared with Other Indices, Pediatr. Pulmonol. , 1995, 20:372-379.
Endogenous production of nitrogen oxide in the human airway has been shown to be increased in patients with asthma and other inflammatory lung diseases. Gaston B., Drazen J., Chee, C, et al. Expired nitric oxide concentrations are elevated in patients with reactive airways disease. Endothelium. 1993; 7:S87; Gustafsson, I.E. , Leone A.M. , Persson M.G., Wiklund Ν.P., Moncada S. , Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. 1991; 181; 2:852-857. However, measurement of gas phase nitric oxide (nitrogen monoxide) per se in the parts per billion range found in the airway requires the use of mass spectrometry or chemiluminescent technology, which are cumbersome, expensive and not reasonably suited for home use.
Moreover, measurement of aqueous phase higher oxides of nitrogen compounds such as S-nitrosothiols, nitrite and nitrate, which are not nitrogen monoxide but which are likewise elevated in concentrations in subjects with inflammatory lung disease, has required that patients be hospitalized for invasive airway sampling procedures, including airway intubation and bronchoalveolar lavage. Gaston, B., Reilly J., Drazen J., et al. , Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc. Natl. Acad. Sci., 1993; 90: 10957-10961.
SUMMARY OF THE INVENTION
The invention provides a device for determination of the content of higher oxides of nitrogen in exhaled breath condensate which comprises a conduit having an exhalate condensing portion with an inlet and an outlet (the inlet canbe configured to fit with a mechanical respirator or, for direct use by the patient, an inlet assembly providing one-way ingress of ambient atmosphere to the device can be associated with the inlet of the conduit exhalate condensing portion); a coolant jacket coaxially surrounding said exhalate condensing portion; a gas release port; and, in enclosed fluid communication with said conduit exhalate condensing portion outlet, a sample assay assembly comprising (i) a translucent analysis chamber attached to the outlet to receive condensate fluid and having a reagent entry port, (ii) a reagent chamber in enclosed fluid communication with the reagent entry port and (iii) a pliable element connecting the outlet and the analysis chamber and forming a portion of the reagent chamber such that flexion of the pliable element closes communication between the outlet and the analysis chamber and contracts the reagent chamber so as to deliver to the analysis chamber controlled amounts of condensate and reagent. The device is disposable and inexpensive, and is used to collect human exhalate for colorimetric assay of liquid and gas phase nitrogen oxides to assist in evaluation of airway inflammation. In a preferred embodiment the device further comprises an inlet assembly providing one-way ingress of ambient atmosphere to the exhalate condensing conduit inlet. This is ideal for the patient who is breathing directly into the device, rather than the situation where the device is connected to a mechanical respirator.
In a preferred embodiment the device further comprises, between the inlet assembly and the exhalate condensing conduit portion, a filter capable of removing particulate matter from exhaled air which passes therethrough.
In another preferred embodiment, the device further comprises a coolant material in the coolant jacket.
In another preferred embodiment, the device further comprises a reagent composition capable of detecting a nitrite or nitrate in an exhalation condensate sample.
In another preferred embodiment, the device further comprises a reagent- permeable membrane in the reagent entry port.
In another preferred embodiment, the device further comprises a rupturable membrane in the reagent entry port.
In another preferred embodiment, the inlet assembly further includes therein a filter capable of removing ambient nitrogen oxides from exhalate passing therethrough.
In another preferred embodiment the exhalate condensing conduit portion comprises a single lumen conduit having a lumen diameter sufficient to cause substantially no resistance to the flow of exhalate therethrough.
In another preferred embodiment the exhalate condensing conduit portion comprises a plurality of conduit tubules having a collective lumen diameter sufficient to cause substantially no resistance to the flow of exhalate therethrough. The puφose of this invention is to condense exhaled lung gas and vapor for aqueous phase nitrogen oxide analyses. This will assist in the evaluation of the human airways' production of nitrogen oxides in both gas and several liquid phase states, including nitrite and nitrate, with potential for multiple other studies to help delineate the lung's redox environment and the airways' degree of inflammation. The investigations which have resulted in the present invention indicate that easily measured liquid phase exhaled nitrogen oxides, nitrite and nitrate, are likewise elevated in asthmatic subjects during periods of inflammation (see abstract enclosed, unpublished data). Utility in the clinical setting for inexpensive and domiciliary evaluation of airway inflammation in various disease states, including asthma, is the primary purpose of the device of the present invention and its utility has been proven, inter alia, as demonstrated herein.
The invention is comprised of cold tolerant materials and consists of two tubing units, one inside the other. Surrounding the inner tube or set of tubes, and contained by the outer tube, is a chemical substance which has a high specific heat, and therefore, once frozen, can maintain freezing temperatures for an extended period of time. The disposable unit can be frozen in a standard size home freezer and then connected together with collection and analysis instruments as a compact integral unit.
Attached to the proximal portion of the unit is a port through which the subject breathes. This consists of two one-way valves which direct atmospheric air or selected gases to the patient's lungs during inspiration, and channel exhaled gas down a condensing tube. Gas moves in only one direction through the condensing apparatus. Inserted between the breathing port's mouthpiece and the condensing chamber is a microporous filter which traps all small part icles( such as saliva or sputum), is impermeable to liquids, but allows gas and vaporized fluids of less than 0.3 microns in diameter to pass. This acts as a saliva trap and may also act as a filter for the larger fluid particles which may be aerosolized in the larger airways. The distal end of the condensing chamber tube(s) is attached to a collecting apparatus which utilizes gravity to trap condensed fluid. At the bottom of this trap is a clear plastic analyzing chamber in which the sample is sequentially warmed, sealed, reacted with colorimetric reagents and analyzed spectrophotometrically by the non-disposable colorimeter.
The patient breathes comfortably in and out through the mouthpiece. Lung fluid vapor collects on the inner surface of the inner tube(s) of the condensing apparatus starting immediately. Gravity carries the larger droplets down the tube, these droplets recruiting other small droplets on their trip to the collecting vial distally. Alternatively, after a fixed period of tidal breathing, the condensed fluid can be expressed down the inner tube with a device similar to a syringe plunger. Aqueous phase nitrite and nitrate can be measured by standard colorimetric assays, and can be reasonably quantified by simple tests performed by patients in their homes.
Brief Description of the Drawings
Figure 1 is a side elevation view, partially in section, of the device of the invention.
Figure 2A is a side sectional elevation view of a preferred embodiment of the sample assay assembly of the device with the non-disposable analyzer, and includes a top view of the connecting pincer valve.
Figure 2B is a top view of the pincer which flexes the pliable element of the sample assay assembly.
Figure 3 is a histogram showing the results of the nitrite assay performed as described in Example 2.
Figure 4 is a histogram showing the results of the nitrate assay performed as described in Example 2. Detailed Description of the Invention
The device of the invention has several advantages, including:
1. This is the only device which measures airway inflammation with a simple home assay, without invasive procedures or expensive and cumbersome testing equipment.
2. Ease of transportability and use of the apparatus.
3. Clinical application for individual patients in their own home or in the clinic or hospital setting to test for or monitor status of asthma or other causes of airway inflammation. May be used to predict disease exacerbations, allowing time for successful early intervention.
4. Clinical applicability in the setting of mechanically ventilated patient to easily monitor airway inflammation.
5. Clinical applicability for measuring airway inflammation in many children too young to cooperate with standard pulmonary function testing, but who can cooperate with tidal breathing through a tube. Similar potential in patients with neuromuscular disease in whom standard tests are uninterpretable.
The device can be made with easily available materials. The cooling substance in the condensing chamber can be water, or a viscous substance with a high specific heat. The device can also be made, as described above, without refrigerant, utilizing a gas/membrane or gas/aqueous reaction compartment.
Referring now to Figure 1 , mouthpiece 1 is formed as an integral element with low resistance one-way valve 2 allowing inspiration of air into the device of the invention resulting from inhalation through it by the user. Low resistance one-way valve 2 optionally contains potassium permanganate and a charcoal filter to remove ambient nitrogen oxides. Mouthpiece 1 and low resistance one-way valve 2 are further integral with low resistance one-way valve 3 to direct all expired gas from the user into the remaining elements of the device. Integral with and downstream of low resistance one-way valve 3 is low resistance filter 4, containing elements which removes all particulates greater than .03 μM in diameter.
Connected downstream to low resistance filter 4 is condensing chamber 5 which consists of either a single, long inert plastic tube of sufficient diameter to be of low resistance to air expired into the device, or a bundle of shorter, parallel, inert plastic tubes of sufficient number to provide minimal resistance to airflow. Condensing chamber 5 is in continuity with, i.e. , receives air arising from filter 4. Coolant chamber or jacket 6 contains an aqueous solution of sufficient osmolality to cause freezing point depression to just above the minimum temperature of the average household freezer, e.g. , in a range of ± 15°F, preferably below 0°F.
Condensing chamber 5 is completely sealed from exposure to coolant chamber 6. Essentially coolant chamber 6 coaxially surrounds condensing chamber 5 so as to control the temperature within condensing chamber 6. Condensing chamber 6 is continuous with a conduit that divides to condensate delivery conduit 7 and exhaust port 8. A reagent imprednated mesh, such as filter paper, can optionally be situated in conduit 7 for reagent combination with condensate prior to their arrival in sample analysis assembly 9. Exhaust port 8 comprises a one-way, low-resistance valve through which air, in which the condensate has been analyzed, is expelled from the device of the invention.
Sample analysis assembly 9 is connected to the outlet of condensing chamber 5 through condensate delivery conduit 7 and is described in detail with reference to Figure 2A.
Analyzer 10 which is not a component of the disposable device of the invention, includes a wavelength-filtered light source and photometer bulb, for measuring the specific absorbance of reacted reagent in sample assay assembly 8, and a computer both for calculating and displaying the corresponding nitrogen oxide content of the sample in assembly 8 and for calibrating the absorbance/concentration relationship based on standard samples is shown as an association of conventional elements in essentially block form. Elements 1 through 9 of the device of the present invention form a disposable unit which is stored under refrigeration, preferably frozen, until used. In contrast, analyzer 10 is not disposable and is maintained at room temperature.
The disposable unit comprising elements 1-9 is removed from frozen storage and placed as a unit in connecting housing 11, which is attached to analyzer 10 in such a way that analysis assembly 9 fits snugly into housing 11. "Housing" serves to hold the disposable and non-disposable units together at the appropriate orientation, and to prevent the subject user's hand from becoming affected by the cold of the disposable device while holding the apparatus during gas sampling. Sample analysis assembly 9 is surrounded by a thermostatically controlled heating coil 12 attached to housing 11 and analyzer 10 which brings the sample and test reagents to 25 °C. Heating coil 12 is part of the non-disposable unit.
Referring now to Figure 2A, illustrated in hatched line is the outlet of condensate delivery conduit 7, which is in enclosed fluid contact with sample assay assembly 9, sample assay assembly 9 comprises continuous with a round, hard- plastic analysis chamber 13, reagent chamber 14 and pliable element 15. Conduit 7 and assembly 9 are brought into juxtaposition and are connected by pliable element 15, which is a soft-plastic component that extends beyond the diameter of conduit 7. At the bottom of analysis chamber 13 is an opening 16 in which is positioned a fluid-permeable membrane or a thin, plastic rupturable membrane.
Reagent(s) for colorimetric nitrogen oxide salt analysis could be a diazo reagent, or such a reagent in conjunction with nitrate reductase and appropriate cofactors to enable both nitrite and nitrate to be measured simultaneously. Other reactions, such as reduction of nitrite and nitrate to nitric oxide in vanadium chloride, followed by reaction with oxyhemoglobin to achieve a colorimetric shift in the Soret band, and including heterolytic cleavage of S-NO bonds with mercuric chloride followed by diazo analysis could also be employed. When exhaled, the condensate of exhaled air passed into analysis chamber 13. Thereafter, the user squeezes pliable element 15, using pincer 17 (shown in Figure 2). When pincer 17 is closed against pliable element 15, this causes the volume of reagent chamber 14 to decrease such that reagent therein is forced upwardly through the permeable or rupturable membrane into analysis chamber 13 to combine and react with the condensate. Thereafter, the reaction product of this chemical reaction is analyzed by colorimetry using the non-disposable colorimeter which passes a path of light through a fixed path of analysis chamber 13.
Potential modifications to the system include:
1. Attachment of an assembly distal to the inspiratory portion which would contain a fiber paper through which the saliva free exhalate is channelled. The filter paper would be impregnated with reagents which react with nitrogen oxides and subsequently change color. A patient could breathe through the filter paper for a given period of time and the degree of color change could be measured against a chart or with a small colorimetric device.
2. Direct attachment to the distal end of the condensing chamber of a filter paper impregnated with dried reagents which will react with the aqueous phase nitrogen oxides to yield a change in color of the paper which can easily be measured in a similar fashion to modification #1 above.
3. Direct attachment of a chamber containing liquid reagents through which the exhalate is bubbled, allowing exhaled nitrogen oxides to directly react with reagents, producing a measurable color change.
4. Attachment of a dehumidifying chamber to the inspiratory portion to eliminate environmental liquid phase nitrogen oxides.
EXAMPLE 1 Expired Nitric Oxide During Tidal Breathing in Humans Recent insights regarding the use of expired nitric oxide (NO*) concentration measurement as an index of airway inflammation cannot be applied to children too young to perform vital capacity (VC) maneuvers. We have therefore developed assays which require only tidal breathing. Sequential colorimetric measurements were made during quiet breathing by reacting dried air expirate (DAE) with Griess reagent under acid conditions. Tidal expired gas NO* production rates (VNO.) were also measured by chemiluminescence over 5 minutes using a 765 liter sealed plethysmograph. Eight control subjects and 6 patients with asthma and cystic fibrosis (CF) were studied. DAE NO- was detected in all normal subject samples with mean (±SD) accumulation curve slope = 40 ± 17 nmoles/liter/breath (p< 0.05 compared with air controls). By comparison, the mean [dissolved nitrogen oxides (NO J collected in a precipitation tube (PT) (-80°C) from size-filtered lung water produced by normal subjects during quiet breathing was 0.8 ±0.1 μM. Tidal VNO/body surface area (specific VNO. [VNO.SP]) was 0.21 ±0.043 μl/min/m2 in normal subjects. Consistent with previous reports based on VC measurements, patients with asthma had higher VNO.SP (0-31 ±0.014 μl/min/m2, p <0.01) and PT NOx (16 ±4.0 μM, p<0.005). Further, patients with CF also had high VN0.Sp (0.34 ± 0.84 μl/m2/min, p <0.005). We report for the first time 1) the detection of NO- in expired air through the use of colorimetric assays; 2) the effort-independent detection of VNO_; and 3) increases in these tidal breath concentrations in patients with asthma and CF. We speculate that tidal-breathing based techniques will have clinical utility both as measures of airway inflammation applicable to home use and as effort- independent measures of airway disease in the pediatric pulmonary function laboratory.
Example 2 Device Evaluation in Human Clinical Study
Asthma is an inflammatory disease which leads to airway obstruction. Current tests of disease severity are based on measures of obstruction, alterations of which are late findings in asthma exacerbations. Recent studies reveal that expression of inducible nitric oxide synthase (iNOS) is increased in the airway epithelial and inflammatory cells of patients with asthma. The activity of iNOS is known to be reflected in high concentrations of nitric oxide (NO • ) gas measured in the expired air of asthmatic subjects. We studied other aqueous phase NOx in asthmatic aspirate in an effort to develop a simple test for airway inflammation applicable to home use.
Subjects
6 normal subjects no smoking history no history of acute, chronic, or recurrent cardiopulmonary, determatologic, gastrointestinal, or neurologic disease.
13 asthmatic patients
3 or more episodes of reversible bronchospasm
I/E ratio <0.5
FEV,/FVC <0.75 at study entry
Methods
Saliva free, 0.2 micron particle size-filtered expired vapor was obtained from subjects breathing quietly through a condensing apparatus.
Nitrite (NO2-) was assayed colorimetrically using Griess reagent.
Nitrate (NO3-) was assayed by chemiluminescence after reduction in vanadium chloride.
Statistical Methods
Mean NO. concentrations were compared using unpaired t-testing. Results are presented as mean, ± standard error. P values of <0.05 were considered significant.
Results As shown in Figure 3, nitrite concentrations were significantly higher in asthmatic subjects (1.877 μM ± 0.36) than in controls (0.902 μM ± 0.08) (p<0.01).
As shown in Figure 4, nitrate concentrations were likewise significantly elevated in asthmatic subjects (9.48 μM ± 1.25) relative to controls (5.27 μM ± 0.51) (p<0.01).
Discussion
Tests of airway obstruction, such as the peak flow meter, are currently the primary modality for objectively assessing severity of inflammatory airway disease. These tests have several limitations, including being effort-dependent, and thus are not suitable for many children and neuro-muscularly handicapped individuals. They also poorly reflect the degree of underlying inflammation.
Utilizing recent insights regarding the biochemistry of higher oxides of nitrogen, we have developed a simple, non-invasive assay for airway inflammation. Tests such as this could be performed at home, and may prove to be useful in longitudinal evaluation and management of asthma, including dosing of anti¬ inflammatory medication.
Conclusion
Aqueous phase nitrogen oxides, measured in condensed exhalate, are significantly elevated in asthmatic patients, and can be used to distinguish between normal and inflamed airways.

Claims

WHAT IS CLAIMED IS;
1. A device for determination of the content of higher oxides of nitrogen in exhaled breath condensate which comprises: a conduit having an exhalate condensing portion with an inlet and an outlet; a coolant jacket coaxially surrounding said exhalate condensing portion; a gas release port; and, in enclosed fluid communication with said conduit exhalate condensing portion outlet, a sample assay assembly comprising
(i) a translucent analysis chamber attached to the outlet to receive condensate fluid and having a reagent entry port,
(ii) a reagent chamber in enclosed fluid communication with the reagent entry port and
(iii) a pliable element connecting the outlet and the analysis chamber and forming a portion of the reagent chamber such that flexion of the pliable element closes communication between the outlet and the analysis chamber and contracts the reagent chamber so as to deliver to the analysis chamber controlled amounts of condensate and reagent.
2. The device of claim 1 which further comprises between the inlet assembly and the exhalate condensing conduit portion, a filter capable of removing particulate matter from exhaled air which passes therethrough.
3. The device of claim 1 which further comprises a coolant material in the coolant jacket.
4. The device of claim 1 which further comprises a reagent composition capable of detecting a nitrite or nitrate in an exhalation condensate sample.
5. The device of claim 1 which further comprises a reagent-permeable membrane in the reagent entry port.
6. The device of claim 1 which further comprises a rupturable membrane in the reagent entry port.
7. The device of claim 1 wherein the inlet assembly further includes therein a filter capable of removing ambient nitrogen oxides from exhalate passing therethrough.
8. The device of claim 1 wherein the exhalate condensing conduit portion comprises a single lumen conduit having a lumen diameter sufficient to cause substantially no resistance to the flow of exhalate therethrough.
9. The device of claim 1 wherein the exhalate condensing conduit portion comprises a plurality of conduit tubules having a collective lumen diameter sufficient to cause substantially no resistance to the flow of exhalate therethrough.
10. The device of claim 1 which further comprises an inlet assembly providing one-way ingress of ambient atmosphere to the exhalate condensing conduit inlet.
PCT/US1997/004848 1996-03-28 1997-03-25 Condensate colorimetric nitrogen oxide analyzer WO1997035519A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002248321A CA2248321C (en) 1996-03-28 1997-03-25 Condensate colorimetric nitrogen oxide analyzer
JP9534575A JP2000507462A (en) 1996-03-28 1997-03-25 Condensate colorimetric nitric oxide analyzer
AU23461/97A AU724417B2 (en) 1996-03-28 1997-03-25 Condensate colorimetric nitrogen oxide analyzer
EP97916226A EP0897284A4 (en) 1996-03-28 1997-03-25 Condensate colorimetric nitrogen oxide analyzer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/623,643 1996-03-28
US08/623,643 US6033368A (en) 1996-03-28 1996-03-28 Condensate colorimetric nitrogen oxide analyzer

Publications (1)

Publication Number Publication Date
WO1997035519A1 true WO1997035519A1 (en) 1997-10-02

Family

ID=24498874

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/004848 WO1997035519A1 (en) 1996-03-28 1997-03-25 Condensate colorimetric nitrogen oxide analyzer

Country Status (6)

Country Link
US (2) US6033368A (en)
EP (1) EP0897284A4 (en)
JP (1) JP2000507462A (en)
AU (1) AU724417B2 (en)
CA (1) CA2248321C (en)
WO (1) WO1997035519A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19951204A1 (en) * 1999-10-15 2001-05-10 Filt Forschungsgesellschaft Fu Apparatus to analyze the components in the exhaled air of a patient forms a condensation to be caught by a filter or storage layer to give a sample passed directly to electrochemical sensors for measurement
EP1139870A1 (en) * 1998-12-18 2001-10-10 The University Of Virginia Patent Foundation Device and method for monitoring asthma
DE10137565A1 (en) * 2001-07-30 2003-03-06 Filt Lungen Und Thoraxdiagnost Method and device for determining parameters of the respiratory condensate
EP1409985A1 (en) * 2000-05-01 2004-04-21 Respiratory Research Inc. Method and device for collecting and analyzing exhaled breath
DE102004009545A1 (en) * 2004-02-24 2005-09-08 Filt Lungen- Und Thoraxdiagnostik Gmbh Sampling method for exhaled air, urine or blood, whereby a cooled probe is placed in the flow that is to be examined so that water vapor and any other substances of interest condense out
DE102005020102B3 (en) * 2005-04-25 2006-11-30 Universität Potsdam Method and device for obtaining and analyzing respiratory condensates
US7364553B2 (en) 2002-12-20 2008-04-29 Amidex, Inc. Breath aerosol management and collection system
DE102008030158A1 (en) * 2008-06-27 2010-02-11 Dina Levina Device for extracting condensate from breathable air of humans and animals, has pipe-shaped line with approximately U-formed curved distribution, which is passed from exhaled air and is connected at outer side with cooling device
WO2010107719A1 (en) * 2009-03-18 2010-09-23 Cardinal Health 207, Inc. Exhaled breath condensate biometric marker measurement apparatus and method
US9357946B2 (en) 2009-04-15 2016-06-07 Nanomix, Inc. Breath condensate sampler and detector and breath/breath condensate sampler and detector
DE102015203719A1 (en) * 2015-03-03 2016-09-08 Robert Bosch Gmbh Apparatus and method for respiratory gas analysis and respiratory gas analyzer
EP2416707B1 (en) * 2009-04-08 2016-10-05 Robert Bosch GmbH Gas analysis apparatus having a combination of gas dehumidifier and gas converter
US11733231B2 (en) 2017-03-20 2023-08-22 Exhalation Technology Limited Breath-condensate analyser

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6033368A (en) * 1996-03-28 2000-03-07 Nitromed, Inc. Condensate colorimetric nitrogen oxide analyzer
US6468222B1 (en) * 1999-08-02 2002-10-22 Healthetech, Inc. Metabolic calorimeter employing respiratory gas analysis
US6612306B1 (en) 1999-10-13 2003-09-02 Healthetech, Inc. Respiratory nitric oxide meter
EP1280449A4 (en) * 2000-04-29 2009-04-08 Univ California An apparatus and method for the estimation of flow-independent parameters which characterize the relevant features of nitric oxide production and exchange in the human lungs
GB0015309D0 (en) * 2000-06-21 2000-08-16 Djupesland Per G Apparatus
US7559324B2 (en) 2000-06-21 2009-07-14 Fisher & Paykel Healthcare Limited Conduit with heated wick
AU2001296456A1 (en) 2000-09-29 2002-04-08 Healthetech, Inc. Indirect calorimetry system
US7335383B2 (en) * 2001-01-16 2008-02-26 The Regents Of The University Of Michigan Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood
DE60229108D1 (en) * 2001-01-16 2008-11-13 Univ Michigan BIOKATALYTIC AND BIOMIMETIC GENERATION OF STICK OXIDE IN SITU ON SUBSTRATE / BLOOD BONDING SURFACES
US7128904B2 (en) * 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
US7347825B2 (en) * 2001-04-17 2008-03-25 University Of Virginia Patent Foundation Device and method for assessing asthma and other diseases
US7118537B2 (en) * 2001-04-30 2006-10-10 Respiratory Research, Inc. Method and device for collecting and analyzing exhaled breath
US20030073918A1 (en) * 2001-10-15 2003-04-17 Orr Joseph A. Configuration-retaining conduit for use in obtaining metabolic measurements from respiration
US6726637B2 (en) 2001-12-06 2004-04-27 Michael Phillips Breath collection apparatus
US7192782B2 (en) * 2002-01-11 2007-03-20 Ekips Technologies, Inc. Method and apparatus for determining marker gas concentration in exhaled breath using an internal calibrating gas
CN100393273C (en) * 2002-02-05 2008-06-11 加利福尼亚大学董事会 Flow-independent parameter estimation based on tidal breathing exhalation profiles
US7220387B2 (en) * 2002-07-23 2007-05-22 Apieron Biosystems Corp. Disposable sensor for use in measuring an analyte in a gaseous sample
US20040017570A1 (en) * 2002-07-23 2004-01-29 Bhairavi Parikh Device and system for the quantification of breath gases
US7352465B2 (en) * 2002-07-23 2008-04-01 Aperon Biosystems Corp. Sample conditioning and environmental control techniques for gas sensor
US7045359B2 (en) 2002-07-26 2006-05-16 Novanox, Llc Method and apparatus to detect a gas by measuring ozone depletion
US20040035187A1 (en) * 2002-08-21 2004-02-26 Allen William C. Collection device for collecting the constituents of air
US20040035186A1 (en) * 2002-08-21 2004-02-26 Allen William C. Interface between a collector and a package
AU2003244171B2 (en) 2002-09-09 2007-11-15 Fisher & Paykel Healthcare Limited Limb for Breathing Circuit
US20040138577A1 (en) * 2002-12-20 2004-07-15 Kline Jeffrey A. Disposable hand-held device for collection of exhaled breath condensate
US7828741B2 (en) * 2002-12-20 2010-11-09 The Charlotte-Mecklenburg Hospital Authority Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia
WO2005082234A1 (en) * 2002-12-30 2005-09-09 Aperon Biosystems Corp. Sensor for measuring an analyte in breath
WO2004073497A2 (en) * 2003-02-14 2004-09-02 The Charlotte-Mecklenburg Hospital Authority Device and method for collection of exhaled alveolar breath condensate
US7101341B2 (en) 2003-04-15 2006-09-05 Ross Tsukashima Respiratory monitoring, diagnostic and therapeutic system
US7493902B2 (en) 2003-05-30 2009-02-24 Fisher & Paykel Healthcare Limited Breathing assistance apparatus
FR2858236B1 (en) 2003-07-29 2006-04-28 Airox DEVICE AND METHOD FOR SUPPLYING RESPIRATORY GAS IN PRESSURE OR VOLUME
US7166201B2 (en) * 2003-12-01 2007-01-23 Sierra Medical Technology Self-condensing pH sensor
US20080214947A1 (en) * 2004-08-20 2008-09-04 Hunt John F Exhaled Breath Condensate Collection and Assay System and Method
US20060058696A1 (en) * 2004-09-10 2006-03-16 Quintron Instrument Company Air sampling apparatus with related sensing and analysis mechanism
US20060200037A1 (en) * 2005-03-02 2006-09-07 Falasco Marianne R System and method for selectively collecting exhaled air
WO2007005758A2 (en) * 2005-06-30 2007-01-11 Mc3, Inc. Methods , compositions and devices for promoting angiogenesis
ATE485849T1 (en) * 2005-12-02 2010-11-15 Univ Michigan POLYMER COMPOSITIONS, COATINGS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF
EP2120708A2 (en) * 2007-02-16 2009-11-25 Universiteit Maastricht Apparatus for and method of condensing exhaled breath
US20080275355A1 (en) * 2007-05-04 2008-11-06 Ekips Technologies, Inc. Method For Diagnosing An Infectioin Condition
GB2451249A (en) * 2007-07-24 2009-01-28 Equine Healthcare Ltd A breath condensate collector
WO2009045163A1 (en) * 2007-10-02 2009-04-09 Anna-Carin Olin Collection and measurement of exhaled particles
US8457706B2 (en) 2008-05-16 2013-06-04 Covidien Lp Estimation of a physiological parameter using a neural network
US8302602B2 (en) 2008-09-30 2012-11-06 Nellcor Puritan Bennett Llc Breathing assistance system with multiple pressure sensors
WO2010075265A2 (en) * 2008-12-23 2010-07-01 The Government Of The United States Of America , As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention Lung aerosol collection device
US20110027899A1 (en) * 2009-02-10 2011-02-03 Hargrove James M Hazardous chemicals detector & methods of use thereof
US8846407B2 (en) 2009-02-10 2014-09-30 James M. Hargrove Chemical explosive detector
US8434479B2 (en) 2009-02-27 2013-05-07 Covidien Lp Flow rate compensation for transient thermal response of hot-wire anemometers
DE102010004611A1 (en) * 2009-08-11 2011-02-17 Aceos Gmbh User unit for the determination of performance parameters from respiratory gas analyzes
US8469031B2 (en) 2009-12-01 2013-06-25 Covidien Lp Exhalation valve assembly with integrated filter
US8439036B2 (en) 2009-12-01 2013-05-14 Covidien Lp Exhalation valve assembly with integral flow sensor
US8469030B2 (en) 2009-12-01 2013-06-25 Covidien Lp Exhalation valve assembly with selectable contagious/non-contagious latch
US8439037B2 (en) 2009-12-01 2013-05-14 Covidien Lp Exhalation valve assembly with integrated filter and flow sensor
EP2515980B8 (en) 2009-12-22 2021-05-19 Fisher & Paykel Healthcare Limited Components for medical circuits
USD655405S1 (en) 2010-04-27 2012-03-06 Nellcor Puritan Bennett Llc Filter and valve body for an exhalation module
USD653749S1 (en) 2010-04-27 2012-02-07 Nellcor Puritan Bennett Llc Exhalation module filter body
USD655809S1 (en) 2010-04-27 2012-03-13 Nellcor Puritan Bennett Llc Valve body with integral flow meter for an exhalation module
US9629971B2 (en) 2011-04-29 2017-04-25 Covidien Lp Methods and systems for exhalation control and trajectory optimization
EA029289B1 (en) * 2011-07-08 2018-03-30 Лайфкью Глоубл Лимитед Personalized nutritional and wellness assistant
US9364624B2 (en) 2011-12-07 2016-06-14 Covidien Lp Methods and systems for adaptive base flow
US9498589B2 (en) 2011-12-31 2016-11-22 Covidien Lp Methods and systems for adaptive base flow and leak compensation
US9144658B2 (en) 2012-04-30 2015-09-29 Covidien Lp Minimizing imposed expiratory resistance of mechanical ventilator by optimizing exhalation valve control
USD731049S1 (en) 2013-03-05 2015-06-02 Covidien Lp EVQ housing of an exhalation module
USD731048S1 (en) 2013-03-08 2015-06-02 Covidien Lp EVQ diaphragm of an exhalation module
USD701601S1 (en) 2013-03-08 2014-03-25 Covidien Lp Condensate vial of an exhalation module
USD736905S1 (en) 2013-03-08 2015-08-18 Covidien Lp Exhalation module EVQ housing
USD692556S1 (en) 2013-03-08 2013-10-29 Covidien Lp Expiratory filter body of an exhalation module
USD693001S1 (en) 2013-03-08 2013-11-05 Covidien Lp Neonate expiratory filter assembly of an exhalation module
USD731065S1 (en) 2013-03-08 2015-06-02 Covidien Lp EVQ pressure sensor filter of an exhalation module
USD744095S1 (en) 2013-03-08 2015-11-24 Covidien Lp Exhalation module EVQ internal flow sensor
US9950135B2 (en) 2013-03-15 2018-04-24 Covidien Lp Maintaining an exhalation valve sensor assembly
US10869614B2 (en) * 2014-12-31 2020-12-22 Koninklijke Philips N.V. System for performing histogram analysis of the time-based capnography signals and method of operation thereof
USD775345S1 (en) 2015-04-10 2016-12-27 Covidien Lp Ventilator console
US11896767B2 (en) 2020-03-20 2024-02-13 Covidien Lp Model-driven system integration in medical ventilators
US20230320623A1 (en) * 2020-08-25 2023-10-12 University Of Tennessee Research Foundation Breath collector and method for diagnosis and/or monitoring
US11846574B2 (en) 2020-10-29 2023-12-19 Hand Held Products, Inc. Apparatuses, systems, and methods for sample capture and extraction

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1143400A1 (en) * 1981-10-15 1985-03-07 1-Й Московский Ордена Ленина И Ордена Трудового Красного Знамени Медицинский Институт Им.И.М.Сеченова Method of determining adequacy of training loads to functional state of sportsman
US5447165A (en) * 1991-09-27 1995-09-05 Gustafsson; Lars E. Method for ascertaining prevailing lung condition and a device

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3373735A (en) * 1965-10-21 1968-03-19 John P. Gallagher Medical-surgical tube
US3544273A (en) * 1968-11-04 1970-12-01 Mine Safety Appliances Co Apparatus for sampling and analyzing breath
US3856051A (en) * 1972-02-28 1974-12-24 J Bain Flexible tube device
US3865106A (en) * 1974-03-18 1975-02-11 Bernard P Palush Positive pressure breathing circuit
US4456008A (en) * 1982-09-13 1984-06-26 Clawson Burrell E Respiratory apparatus and method
US4485822A (en) * 1983-01-28 1984-12-04 G & R Instrument Company, Inc. Multi-phase interfacing system and method
US4446869A (en) * 1983-03-07 1984-05-08 Trimed, Inc. Water absorbing trap to protect an infrared exhaled carbon dioxide apnea monitor of a patient's respiration
US4609537A (en) * 1984-08-13 1986-09-02 Standard Oil Company (Indiana) Process for simultaneously removing nitrogen oxides, sulfur oxides, and particulates
US5173264A (en) * 1986-08-04 1992-12-22 The United States Of America As Represented By The United States Department Of Energy High throughput liquid absorption preconcentrator sampling instrument
US4821737A (en) * 1986-08-25 1989-04-18 The Boc Group, Inc. Water separator
US4713095A (en) * 1986-10-16 1987-12-15 Criticare Systems, Inc. Liquid separator for gas analyzer
FI82367C (en) * 1988-02-11 1991-03-11 Instrumentarium Oy Spirometer coupled to intubation tube and sampling connection in g asanalyzer
US4945918A (en) * 1988-05-04 1990-08-07 Abernathy Charles M Method and apparatus for monitoring a patient's circulatory status
US5305762A (en) * 1992-09-21 1994-04-26 Medical Graphics Corporation Patient valve incorporating one-way check valves for infection control
US5361771A (en) * 1993-03-05 1994-11-08 Western Research Company, Inc. Portable pulmonary function testing device and method
DE9421065U1 (en) * 1994-05-13 1995-05-11 Filt Forschungsgesellschaft Fu Device for collecting exhaled breath condensate
GB9417421D0 (en) * 1994-08-30 1994-10-19 Williams Deryk J P Lung desease management system
US6033368A (en) * 1996-03-28 2000-03-07 Nitromed, Inc. Condensate colorimetric nitrogen oxide analyzer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1143400A1 (en) * 1981-10-15 1985-03-07 1-Й Московский Ордена Ленина И Ордена Трудового Красного Знамени Медицинский Институт Им.И.М.Сеченова Method of determining adequacy of training loads to functional state of sportsman
US5447165A (en) * 1991-09-27 1995-09-05 Gustafsson; Lars E. Method for ascertaining prevailing lung condition and a device

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP0897284A4 *

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU776296B2 (en) * 1998-12-18 2004-09-02 University Of Virginia Patent Foundation Device and method for monitoring asthma
EP1139870A1 (en) * 1998-12-18 2001-10-10 The University Of Virginia Patent Foundation Device and method for monitoring asthma
US6585661B1 (en) 1998-12-18 2003-07-01 University Of Virginia Patent Foundation Device and method for monitoring asthma
EP1139870A4 (en) * 1998-12-18 2004-07-28 Univ Virginia Device and method for monitoring asthma
DE19951204C2 (en) * 1999-10-15 2002-08-08 Filt Forschungsgesellschaft Fu Procedure for analyzing the ingredients in exhaled air
DE19951204A1 (en) * 1999-10-15 2001-05-10 Filt Forschungsgesellschaft Fu Apparatus to analyze the components in the exhaled air of a patient forms a condensation to be caught by a filter or storage layer to give a sample passed directly to electrochemical sensors for measurement
EP1409985A1 (en) * 2000-05-01 2004-04-21 Respiratory Research Inc. Method and device for collecting and analyzing exhaled breath
EP1409985A4 (en) * 2000-05-01 2009-01-07 Respiratory Res Inc Method and device for collecting and analyzing exhaled breath
DE10137565B4 (en) * 2001-07-30 2004-07-15 Filt Lungen- Und Thoraxdiagnostik Gmbh Method for determining parameters of a breath condensate
DE10137565A1 (en) * 2001-07-30 2003-03-06 Filt Lungen Und Thoraxdiagnost Method and device for determining parameters of the respiratory condensate
US7144741B2 (en) 2001-07-30 2006-12-05 Michael Rothe Process and apparatus for the determination of parameters of a breath condensate
US7364553B2 (en) 2002-12-20 2008-04-29 Amidex, Inc. Breath aerosol management and collection system
DE102004009545A1 (en) * 2004-02-24 2005-09-08 Filt Lungen- Und Thoraxdiagnostik Gmbh Sampling method for exhaled air, urine or blood, whereby a cooled probe is placed in the flow that is to be examined so that water vapor and any other substances of interest condense out
DE102005020102B3 (en) * 2005-04-25 2006-11-30 Universität Potsdam Method and device for obtaining and analyzing respiratory condensates
DE102008030158A1 (en) * 2008-06-27 2010-02-11 Dina Levina Device for extracting condensate from breathable air of humans and animals, has pipe-shaped line with approximately U-formed curved distribution, which is passed from exhaled air and is connected at outer side with cooling device
WO2010107719A1 (en) * 2009-03-18 2010-09-23 Cardinal Health 207, Inc. Exhaled breath condensate biometric marker measurement apparatus and method
EP2416707B1 (en) * 2009-04-08 2016-10-05 Robert Bosch GmbH Gas analysis apparatus having a combination of gas dehumidifier and gas converter
US9357946B2 (en) 2009-04-15 2016-06-07 Nanomix, Inc. Breath condensate sampler and detector and breath/breath condensate sampler and detector
DE102015203719A1 (en) * 2015-03-03 2016-09-08 Robert Bosch Gmbh Apparatus and method for respiratory gas analysis and respiratory gas analyzer
US11733231B2 (en) 2017-03-20 2023-08-22 Exhalation Technology Limited Breath-condensate analyser
US11885794B2 (en) 2017-03-20 2024-01-30 Exhalation Technology Limited Breath-condensate device

Also Published As

Publication number Publication date
JP2000507462A (en) 2000-06-20
CA2248321A1 (en) 1997-10-02
EP0897284A1 (en) 1999-02-24
CA2248321C (en) 2003-03-18
AU2346197A (en) 1997-10-17
AU724417B2 (en) 2000-09-21
US6033368A (en) 2000-03-07
US6419634B1 (en) 2002-07-16
EP0897284A4 (en) 1999-05-19

Similar Documents

Publication Publication Date Title
US6419634B1 (en) Condensate colorimetric nitrogen oxide analyzer
Horváth et al. A European Respiratory Society technical standard: exhaled biomarkers in lung disease
US6585661B1 (en) Device and method for monitoring asthma
Horváth et al. Exhaled breath condensate: methodological recommendations and unresolved questions
Högman et al. Exhaled nitric oxide partitioned into alveolar, lower airways and nasal contributions
EP1496789B1 (en) Improved breath collection apparatus
US4671298A (en) Isothermal rebreathing apparatus and method
Turner et al. An exploratory comparative study of volatile compounds in exhaled breath and emitted by skin using selected ion flow tube mass spectrometry
CA2660122C (en) Condensate glucose analyzer
US20020026937A1 (en) Respiratory gas sensors in folw path
US6612306B1 (en) Respiratory nitric oxide meter
O'hara et al. Development of a protocol to measure volatile organic compounds in human breath: a comparison of rebreathing and on-line single exhalations using proton transfer reaction mass spectrometry
Mukhopadhyay Don't waste your breath
Kissoon et al. FE NO: relationship to exhalation rates and online versus bag collection in healthy adolescents
US11598723B2 (en) NDIR sensor, sampling method and system for breath analysis
Ohlsson et al. Accurate measurement of blood alcohol concentration with isothermal rebreathing.
WO2002017991A2 (en) Respiratory gas sensors in flow path
Shin et al. Flow-independent nitric oxide exchange parameters in cystic fibrosis
Canady et al. Vital capacity reservoir and online measurement of childhood nitrosopnea are linearly related: clinical implications
Franklin et al. Variability of nitric oxide metabolites in exhaled breath condensate
WO2017189546A1 (en) Breath analysis device
CA2312808C (en) A device for examining respiratory diseases, and diagnostic agents
JPH0647047A (en) Method for clinical inspection of expiration and device therefor
JPH10186A (en) Method and device of analyzing specified gas component in expired air
Periago et al. Design and evaluation of an exhaled breath sampler for biological monitoring of organic solvents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2248321

Country of ref document: CA

Ref country code: CA

Ref document number: 2248321

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1997916226

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997916226

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997916226

Country of ref document: EP